Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Longton

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Epidemiology|November 6, 2007
Integrating the predictiveness of a marker with its performance as a classifierMargaret S Pepe, Ziding Feng, Ying Huang, et al.
Oncogene|December 3, 2003
Distinct roles for p53, p27Kip1, and p21Cip1 during tumor developmentJeannette Philipp-Staheli, Kyung-Hoon Kim, Denny Liggitt, et al.
Cancer Cell|June 28, 2002
Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant miceJeannette Philipp-Staheli, Kyung-Hoon Kim, Shannon R Payne, et al.
Molecular and Cellular Biology|October 24, 2007
p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instabilityShannon R Payne, Shulin Zhang, Karen Tsuchiya, et al.
Journal of Cutaneous Pathology|June 2, 2016
Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi methodPatricia A Carney, Lisa M Reisch, Michael W Piepkorn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2014
Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of diseaseJeffrey R Marks, Karen S Anderson, Paul Engstrom, et al.
JAMA Oncology|December 23, 2016
Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast CancerLisa A Newman, Azadeh Stark, Dhanajay Chitale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2008
Diagnostic markers for early detection of ovarian cancerIrene Visintin, Ziding Feng, Gary Longton, et al.
Breast Cancer Research and Treatment|September 8, 2017
Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costsAnna N A Tosteson, Qian Yang, Heidi D Nelson, et al.
BMC Women'S Health|February 6, 2013
Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS)Natalia V Oster, Patricia A Carney, Kimberly H Allison, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Epidemiology|November 6, 2007
Integrating the predictiveness of a marker with its performance as a classifierMargaret S Pepe, Ziding Feng, Ying Huang, et al.
Oncogene|December 3, 2003
Distinct roles for p53, p27Kip1, and p21Cip1 during tumor developmentJeannette Philipp-Staheli, Kyung-Hoon Kim, Denny Liggitt, et al.
Cancer Cell|June 28, 2002
Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant miceJeannette Philipp-Staheli, Kyung-Hoon Kim, Shannon R Payne, et al.
Molecular and Cellular Biology|October 24, 2007
p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instabilityShannon R Payne, Shulin Zhang, Karen Tsuchiya, et al.
Journal of Cutaneous Pathology|June 2, 2016
Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi methodPatricia A Carney, Lisa M Reisch, Michael W Piepkorn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2014
Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of diseaseJeffrey R Marks, Karen S Anderson, Paul Engstrom, et al.
JAMA Oncology|December 23, 2016
Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast CancerLisa A Newman, Azadeh Stark, Dhanajay Chitale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2008
Diagnostic markers for early detection of ovarian cancerIrene Visintin, Ziding Feng, Gary Longton, et al.
Breast Cancer Research and Treatment|September 8, 2017
Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costsAnna N A Tosteson, Qian Yang, Heidi D Nelson, et al.
BMC Women'S Health|February 6, 2013
Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS)Natalia V Oster, Patricia A Carney, Kimberly H Allison, et al.
Pageof 3